PorciSafe PRRS Inac
Porcine Reproductive and Respiratory Syndrome Vaccine, Inactivated ( Strain CH-1a )
Porcine Reproductive and Respiratory Syndrome Vaccine, Inactivated ( Strain CH-1a )
The Porcine Reproductive and Respiratory Syndrome Vaccine, Inactivated (Strain CH-1a), addresses the prevention of infectious porcine reproductive and respiratory syndrome. This vaccine is designed for sows, breeding boars, and piglets, offering a six-month immunization period. It is a milky emulsion containing the porcine reproductive and respiratory syndrome virus, ensuring effective protection when administered as directed.
Key Highlights
- Designed to prevent infectious porcine reproductive and respiratory syndrome.
- Contains inactivated virus with a content of ≥2×107.0 TCID50/ml.
- Provides a six-month immunization period.
- Suitable for sows, breeding boars, and piglets.
- Intramuscular injection into the neck for easy administration.
Product Characteristics
High Antigen Content
Advanced antigen culture process ensures antigen levels 10 times higher than standards.
Adopts whole-virus complex epitope antigen technology for excellent stability and long-lasting immunity.
Efficient Avoidance of ADE
Neutralisation of epitope antigen induces strong cellular and antibody response.
Prevents ADE (antibody-dependent enhancement) effect by sealing off enhanced infection targets.
Provides broad cross-protection against classical, variant, and NADC30-like PRRSV strains.
Advanced Immune Stimulation
Uses specialised immune adjuvant with shear double-cycle emulsification, forming complete nano-microspheres for efficient absorption and low stress.
Contains immune enhancers that boost both non-specific and specific immunity, improving antibody production.
High Safety Standards
Produced with serum-free medium and advanced purification technology.
Removes 99% of impurities and ensures no contamination with protein stressors.
No risk of dispersal, mutation, or recombination.
Suitable for PRRSV-stable and PRRSV-unstable farms.
Target Use
- Species: Swine (sows, breeding boars, piglets)
- Indications: Prevention of porcine reproductive and respiratory syndrome
- Production Stages: Sows during pregnancy, breeding boars, piglets at 21 days of age
- Usage Scenarios: Farms, breeding facilities
Composition & Presentation
- Antigen: Porcine reproductive and respiratory syndrome virus, inactivated
- Dosage Form: Milky emulsion
- Vial Volumes: 20 ml, 50 ml, 100 ml
- Route of Administration: Intramuscular injection into the neck
Directions for Use
- Recommended Dose:
- Sows: 4 ml within 40 days of pregnancy, second dose after 20 days, then every 6 months
- Breeding Boars: 4 ml at the same schedule as sows
- Piglets: 2 ml at 21 days of age
- Route: Intramuscular injection into the neck
- Withdrawal Period: Vaccination not allowed 21 days before slaughter
Storage & Stability
- Temperature Range: Store at 2–8°C
- Shelf Life: 18 months unopened
Safety & Precautions
- Adverse Reactions: Some pigs may experience mild swelling at the injection site, typically disappearing within 21 days.
- Handling/Biosecurity Notes: Return to room temperature and shake well before use; strictly disinfect injection site.
Regulatory & Packaging Information
- Pack Sizes/Contents: 20 ml, 50 ml, 100 ml bottles; various case sizes
- Product Codes:SYSZ240051054
- Manufacturer: Guizhou Firstv Biological Technology Co. Ltd
FAQ
A: Approximately 6 months.
A: Yes, piglets can receive 2 ml at 21 days of age.